Skip to main content
Top

Calcified Tissue International

Issue 4/2006

Content (8 Articles)

Laboratory Investigations

Partial Prevention of Long-Term Femoral Bone Loss in Aged Ovariectomized Rats Supplemented with Choline-Stabilized Orthosilicic Acid

M. Calomme, P. Geusens, N. Demeester, G. J. Behets, P. D’Haese, J. B. Sindambiwe, V. Van Hoof, D. Vanden Berghe

Sprouty Genes Are Expressed in Osteoblasts and Inhibit Fibroblast Growth Factor-Mediated Osteoblast Responses

X. Yang, J. B. Webster, D. Kovalenko, R. J. Nadeau, O. Zubanova, P.-Y. Chen, R. Friesel

Effects of Lanthanum on Composition, Crystal Size, and Lattice Structure of Femur Bone Mineral of Wistar Rats

J. Huang, T.-L. Zhang, S.-J. Xu, R.-C. Li, K. Wang, J. Zhang, Y.-N. Xie

Endocytosis of Tartrate-Resistant Acid Phosphatase by Osteoblast-Like Cells Is Followed by Inactivation of the Enzyme

S. Perez-Amodio, D. C. Jansen, W. Tigchelaar-Gutter, W. Beertsen, V. Everts

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine